Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral sildenafil added to milrinone in infants with pulmonary hypertension
IRCT20190731044393N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in pulmonary hypertension (PH) comparing Sildenafil + milrinone with Milrinone alone (2 arms). Primary endpoint: Changes in the treatment process and improvement of pulmonary hypertension. Started Sep 2019; status: completed.
02
Drugs
sildenafilmilrinone
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on IRCT20190731044393N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190731044393N1.